SuperworthOrthofix Medical EPS OFIX
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$1.54
- Latest quarter, Q2 FY26
- −$0.39
- Fiscal year 2025
- −$2.34
Orthofix Medical's earnings per share was −$1.54 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.39.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2.34 | n/a |
| FY2024 | −$3.29 | n/a |
| FY2023 | −$4.15 | n/a |
| FY2022 | −$0.98 | n/a |
| FY2021 | −$1.72 | −1533% |
| FY2020 | $0.12 | n/a |
| FY2019 | −$1.52 | −314% |
| FY2018 | $0.71 | +115% |
| FY2017 | $0.33 | +120% |
| FY2016 | $0.15 | n/a |
| FY2015 | −$0.15 | n/a |
| FY2014 | −$0.47 | n/a |
| FY2013 | −$1.60 | −173% |
| FY2012 | $2.19 | n/a |
| FY2011 | −$0.13 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.39 | n/a | −$1.54 | |
| Q1 FY26 | −$0.52 | n/a | −$1.51 | |
| Q4 FY25 | −$0.06 | n/a | −$2.34 | |
| Q3 FY25 | −$0.57 | n/a | −$3.03 | |
| Q2 FY25 | −$0.36 | n/a | −$3.17 | |
| Q1 FY25 | −$1.35 | n/a | −$3.69 | |
| Q4 FY24 | −$0.75 | n/a | −$3.29 | |
| Q3 FY24 | −$0.71 | n/a | −$3.14 | |
| Q2 FY24 | −$0.88 | n/a | −$3.20 | |
| Q1 FY24 | −$0.95 | n/a | −$3.39 | |
| Q4 FY23 | −$0.60 | n/a | −$4.15 | |
| Q3 FY23 | −$0.77 | n/a | −$3.90 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orthofix Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| OFIXOrthofix Medical | −$1.54 | |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| MOVMovado | $1.80 | +137% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Orthofix Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.